We found that the blockade of IL-10 markedly attenuated the inhibitory effect of MS, as shown by exacerbated colon inflammation, exaggerated weight loss, higher DAI and elevated amount of IL-6 (Fig. 6E). Here, IL10 is linked to myeloid sarcoma.